Leaders in Pharmaceutical Business Intelligence announces the FIRST book of their BioMedical Series

Leaders in Pharmaceutical Business Intelligence, launched in April 2012 as an Open Access Online Scientific Journal, would like to announce the FIRST book of their BioMedical E-Book Series, Perspectives on Nitric Oxide in Disease Mechanisms, which is now available on Amazon Kindle. This book is a comprehensive review of Nitric Oxide, its discovery, function, and related opportunities for targeted therapy written by PhDs, MDs, MD/PhDs, PharmDs.
 
Papers published in PubMed
Papers published in PubMed
July 18, 2013 - PRLog -- Leaders in Pharmaceutical Business Intelligence, launched in April 2012 as an Open Access Online Scientific Journal (http://pharmaceuticalintelligence.com), would like to announce the FIRST book of their BioMedical E-Book Series, Perspectives on Nitric Oxide in Disease Mechanisms, which is now available on Amazon Kindle (http://www.amazon.com/dp/B00DINFFYC). This book is a comprehensive review of Nitric Oxide, its discovery, function, and related opportunities for targeted therapy written by PhDs, MDs, MD/PhDs, PharmDs.    

Leaders in Pharmaceutical Business Intelligence is a scientific, medical and business multi-expert authoring environment in several domains of life sciences, pharmaceutical, healthcare & medical industries. The venture operates as an online scientific intellectual exchange at their website http://pharmaceuticalintelligence.com and for curation and reporting on frontiers in biomedical, biological sciences, healthcare economics, pharmacology, pharmaceutical & medicine.  In addition the venture publishes a BioMedical E-book Series available on Amazon’s Kindle platform (future titles at http://pharmaceuticalintelligence.com/biomed-e-books/).

Analyzing and sharing the vast amounts of scientific knowledge has never been so crucial to innovation in the medicalfield.The publication rate has steadily increased from the 70’s, with a 50% increase in the number of original research articles published from the 1990’s to the previous decade.  This massive amount of biomedical and scientific information has presented the unique problem of an information overload, and the critical need for methodology and expertise to organize, curate, and disseminate this diverse information for scientists and clinicians. Dr. Larry Bernstein, President of Triplex Consulting and previously chief of pathology at New York’s Methodist Hospital, concurs that “the academic pressures to publish, and the breakdown of knowledge into “silos”, has contributed to this knowledge explosion and although the literature is now online and edited, much of this information is out of reach to the very brightest clinicians.”

Traditionally, organization of biomedical information has been the realm of the literature review, but most reviews are performed years after discoveries are made and, given the rapid pace of new discoveries, this is appearing to be an outdated model.  In addition, most medical searches are dependent on keywords, hence adding more complexity to the investigator in finding the material they require.  Third, medical researchers and professionals are recognizing the need to converse with each other, in real-time, on the impact new discoveries may have on their research and clinical practice.

These issues require a people-based strategy, having expertise in a diverse and cross-integrative number of medical topics to provide the in-depth understanding of the current research and challenges in each field as well as providing a more conceptual-based search platform.  To address this need, human intermediaries, known as scientific curators, are needed to narrow down the information and provide critical context and analysis of medical and scientific information in an interactive manner powered by web 2.0 with curators referred to as the “researcher 2.0”.  This curation offers better organization and visibility to the critical information useful for the next innovations in academic, clinical, and industrial research by providing these hybrid networks.

We are addressing the need to organize the massive amount of scientific information by:

Ø          1)   delivering curation and summary interpretations of latest  findings and innovations on an open-access, Web 2.0 platform with future goals of providing primarily concept-driven search

Ø          2)   providing a social platform for scientists and clinicians to enter into discussion using social media

Ø          3)  compiling recent discoveries and issues in yearly-updated BioMedical E-book Series on Amazon’s mobile Kindle platform.

Photo:
https://www.prlog.org/12177251/1
End
Email:***@alum.berkeley.edu
Tags:Pharmaceutical, Analysis, Blog, Biomedical, Book, Kindle
Industry:Publishing, Science, Biotech
Location:United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Page Updated Last on: Jul 18, 2013
Leaders in Pharmaceutical Business Intelligence News



Like PRLog?
9K2K1K
Click to Share